Wellington Management Company »

Monopar Therapeutics shares owned by Wellington Management Company

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $19M 232k 81.67

More positions owned by Wellington Management Company

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Wells Fargo & Company (WFC)
Merck & Co (MRK)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Sempra Energy (SRE)
JPMorgan Chase & Co. (JPM)

View all positions for Wellington Management Company

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Wellington Management Company
Vanguard Group
BlackRock
Deerfield Management Company
Saturn V Capital Management
TCG Crossover Management
ADAR1 Capital Management
Vivo Capital
Geode Capital Management
Affinity Asset Advisors
State Street Corporation
Driehaus Capital Management

View all funds holding Monopar Therapeutics